Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Aminoacylase 1 deficiency: case report on three affected siblings

V. Smolka, D. Friedecky, J. Kolarova, O. Tkacik, H. Foltenova, V. Bekarek, P. Vrtel, J. Srovnal

. 2024 ; 8 (-) : 18. [pub] 20231211

Status neindexováno Jazyk angličtina Země Čína

Typ dokumentu kazuistiky

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006105

BACKGROUND: Aminoacylase 1 (ACY1, EC 3.5.1.14) deficiency (ACY1D) is a very rare inherited metabolic disease (IMD) with autosomal recessive inheritance (OMIM #609924). Up to date, only 15 cases have been reported in the literature. It is diagnosed by detecting acetylated amino acids among the patient's urine organic acids by gas chromatography-mass spectrometry. Its clinical manifestations are highly variable, ranging from severe neurological symptoms to being asymptomatic. CASE DESCRIPTION: We present a 14-year-old boy with mild intellectual disability, speech sound disorder and non-alcoholic fatty liver disease who exhibited increased urinary excretion of N-acetylalanine, N-acetylmethionine and N-acetylglutamine during testing for inherited metabolic disorders. A suspected ACY1D was subsequently confirmed by targeted next generation sequencing, which revealed the presence of a homozygous pathogenic missense mutation in the ACY1 gene, c.1057C>T (p.Arg353Cys). The proband underwent speech education with good outcome. The same homozygous mutation in ACY1 gene was found in the boy's two brothers, who exhibited slightly varied intellectual abilities. Follow-up examinations of the siblings revealed no deterioration in their mental skills. CONCLUSIONS: These results suggest that uneven mental abilities in pediatric patients with various disorders including autism spectrum disorder may be sufficient grounds to warrant metabolic testing for ACY1D. The acylglycines urine excretion could be a promising novel metabolic marker for ACY1D testing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006105
003      
CZ-PrNML
005      
20240412130932.0
007      
ta
008      
240405e20231211cc f 000 0|eng||
009      
AR
024    7_
$a 10.21037/acr-23-46 $2 doi
035    __
$a (PubMed)38234346
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a Smolka, Vratislav $u Department of Paediatrics, University Hospital Olomouc, Olomouc, Czech Republic
245    10
$a Aminoacylase 1 deficiency: case report on three affected siblings / $c V. Smolka, D. Friedecky, J. Kolarova, O. Tkacik, H. Foltenova, V. Bekarek, P. Vrtel, J. Srovnal
520    9_
$a BACKGROUND: Aminoacylase 1 (ACY1, EC 3.5.1.14) deficiency (ACY1D) is a very rare inherited metabolic disease (IMD) with autosomal recessive inheritance (OMIM #609924). Up to date, only 15 cases have been reported in the literature. It is diagnosed by detecting acetylated amino acids among the patient's urine organic acids by gas chromatography-mass spectrometry. Its clinical manifestations are highly variable, ranging from severe neurological symptoms to being asymptomatic. CASE DESCRIPTION: We present a 14-year-old boy with mild intellectual disability, speech sound disorder and non-alcoholic fatty liver disease who exhibited increased urinary excretion of N-acetylalanine, N-acetylmethionine and N-acetylglutamine during testing for inherited metabolic disorders. A suspected ACY1D was subsequently confirmed by targeted next generation sequencing, which revealed the presence of a homozygous pathogenic missense mutation in the ACY1 gene, c.1057C>T (p.Arg353Cys). The proband underwent speech education with good outcome. The same homozygous mutation in ACY1 gene was found in the boy's two brothers, who exhibited slightly varied intellectual abilities. Follow-up examinations of the siblings revealed no deterioration in their mental skills. CONCLUSIONS: These results suggest that uneven mental abilities in pediatric patients with various disorders including autism spectrum disorder may be sufficient grounds to warrant metabolic testing for ACY1D. The acylglycines urine excretion could be a promising novel metabolic marker for ACY1D testing.
590    __
$a NEINDEXOVÁNO
655    _2
$a kazuistiky $7 D002363
700    1_
$a Friedecky, David $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Kolarova, Jana $u Department of Clinical Psychology, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Tkacik, Oksana $u Department of Paediatrics, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Foltenova, Hana $u Department of Paediatrics, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Bekarek, Vojtech $u Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Vrtel, Petr $u Institute of Medical Genetics, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Srovnal, Josef $u Institute of Medical Genetics, University Hospital Olomouc, Olomouc, Czech Republic $u Laboratory of Experimental Medicine, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czech Republic $u Cancer Research Czech Republic, Olomouc, Olomouc, Czech Republic
773    0_
$w MED00214680 $t AME case reports $x 2523-1995 $g Roč. 8 (20231211), s. 18
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38234346 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412130924 $b ABA008
999    __
$a ok $b bmc $g 2076128 $s 1215867
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 8 $c - $d 18 $e 20231211 $i 2523-1995 $m AME case reports $n AME Case Rep $x MED00214680
LZP    __
$a Pubmed-20240405

Najít záznam

Citační ukazatele

Možnosti archivace